For TRAIL-resistant cancer cells such as A549, combination chemotherapy could be a useful method, as exposure to a chemotherapeutic agent might render cancer cells more susceptible to TRAIL apoptosis [34]. This evidence concerns the gene TNFSF10 and cancer.